US Stocks
/
Cartesian Therapeutics, Inc. Share Price
Cartesian Therapeutics, Inc. Share Price

Cartesian Therapeutics, Inc. Share Price

NASDAQ: RNAC | Micro Cap
$6.82
+$0.15 (2.17%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cartesian Therapeutics, Inc. Stock Performance

Open
$6.74
Prev. Close
$6.67
Circuit Range
N/A
Day Range
$6.71 - $6.79
Year Range
$5.66 - $10.88
Volume
5,444
Average Traded
$6.75

Cartesian Therapeutics, Inc. Share Price Today

As of 9 October 2026, Cartesian Therapeutics, Inc.'s share price is $6.82. The stock opened at $6.74, compared to its previous close of $6.67. During today's trading session, Cartesian Therapeutics, Inc.'s share price traded between $6.71 and $6.79, with an average price of $6.75. Over the past 52 weeks, the stock has recorded a high of $10.88 and a low of $5.66. In terms of performance, Cartesian Therapeutics, Inc.'s share price has risen by 9.56% over the last six months and is down 16.46% on a year-on-year basis.

Cartesian Therapeutics, Inc. Share Price Chart

$6.71$6.79
L
Show Current Price
H

Cartesian Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$177.14M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.09
Revenue (TTM)
$2.80B
Return On Equity (TTM)
122.93%
Profit Margin
-4653.57%
Debt to Equity
-0.42
Quarterly Earnings Growth YoY
138.22%

Cartesian Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.45$0.95$0.08$0.00
Net Profit-$35.90-$92.58-$39.18$13.72
Net Profit Margin-7977.78%-9745.26%-48975.00%N/A
Income ChangeN/A-157.88%57.68%135.02%

Cartesian Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$26.00$38.91$2.80
Net Profit-$257.26-$77.42-$130.30
Net Profit Margin-989.46%-198.97%-4653.57%
Income ChangeN/A69.91%-68.30%

About Cartesian Therapeutics, Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Cartesian Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$7.20
$6.78
-6.48%
Sep 2026
$9.02
$7.25
-27.43%
Aug 2026
$7.86
$9.99
+28.74%
Jul 2026
$10.30
$7.76
-25.53%
Jun 2026
$7.43
$10.42
+38.56%
May 2026
$6.33
$7.52
+20.80%
Apr 2026
$6.38
$6.22
+0.81%
Mar 2026
$7.36
$6.17
-18.64%
Feb 2026
$6.96
$7.59
+10.16%
Jan 2026
$7.23
$6.89
-4.31%
Dec 2025
$7.30
$7.20
-4.26%
Nov 2025
$8.19
$7.52
-7.89%

RNAC Share Price FAQs

What is Cartesian Therapeutics, Inc. share price today?

chevron-up
Cartesian Therapeutics, Inc. share price today is $6.82 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Cartesian Therapeutics, Inc. stock?

chevron-up
The 52 week high of Cartesian Therapeutics, Inc. stock is $10.88, while the 52 week low is $5.66 as of 9 Oct '26.

What is RNAC's market capitalisation today?

chevron-up
RNAC market capitalisation is $177.14M as of October 9, 2026, at 7:15 am IST.

What is RNAC's net income for the last quarter?

chevron-up
RNAC's net income for the last quarter is 13.72B USD.

What is the 5 year returns of RNAC?

chevron-up
The 5 year returns of RNAC is -93.67% as on 9 Oct '26.

What is the high & low stock price of RNAC today?

chevron-up
RNAC stock price hit a high of $6.79 and low of $6.71 as of 9 Oct '26.

Can I buy RNAC shares in India?

chevron-up
Yes. You can buy RNAC in India by opening an international trading account.